Life Sciences Cos. Eye $1.5B Through Follow-On Offerings
At least 12 publicly traded life sciences companies have launched stock offerings since Tuesday, targeting nearly $1.5 billion in capital as biotech, biopharmaceutical and medical device companies continue to tap the...To view the full article, register now.
Already a subscriber? Click here to view full article